Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs

Environmental Toxicology and Pharmacology

Volumn 31, Issue 1, 2011, Pages 250-257

  Bouraoui, Sana ^a   Brahem, Aicha ^a   Tabka, Faten ^a   Mrizek, Najib ^a   Saad, Ali ^a   Elghezal, Hatem ^a,b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF SOUSSE   (Tunisia)

Author keywords

Chromosomal aberration test; Cytotoxic drug; Micronuclei test; Occupational exposure; Proliferation rate index

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT;

ADULT; ARTICLE; CELL PROLIFERATION; CHROMATID ABERRATION; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; NURSE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SISTER CHROMATID EXCHANGE; STRUCTURAL CHROMOSOME ABERRATION; TUNISIA;

ADULT; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; FEMALE; GLOVES, PROTECTIVE; HUMANS; KINETICS; LYMPHOCYTES; MALE; MASKS; MICRONUCLEUS TESTS; NURSES; OCCUPATIONAL EXPOSURE; PROTECTIVE CLOTHING; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK MANAGEMENT; SMOKING; TUNISIA;

EID: 78650227291     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.11.004     Document Type: Article

References (47)

1. Anwar W.A. Assessment of cytogenetic changes in human populations out risk in Egypt. Mutat. Res. 1994, 313:183-191.
2. Arlett C., Ashty J., Fiedler R., Scott D. Micronuclei: origin, applications and methodologies, a workshop sponsored by the health and safety executive held in Manchester. Mutagenesis 1989, 4:5-482.
3. Baker E.S., Conor T.H. Monitoring occupational exposure to cancer chemotherapy drugs. Am. J. Health Syst. Pharm. 1996, 53:2713-2723.
4. Benhamou S., Pot-Deprun J., Sancho-Garnier H., Chouroun-Linkov I. Sister-chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatic agents. Int. J. Cancer 1988, 41:350-353.
5. Bonassi S., Znaor A., Norppa H., Hagmar L. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet. Genome Res. 2004, 104:376-382.
6. Burgaz S., Karahlil B., Bayrak P., Taskin L., Yavuzaslam F., Bokesoy I., Bos R.P., Nurgun P. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling anti-neoplastics. Mutat. Res. 1999, 439:97-104.
7. Burgaz S., Karahalil B., Canli Z., Terzioglu F., Ancel G., Anzion R.B., Bos R.P., Huttner E. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations. Human Exp. Toxicol. 2002, 21:192-195.
8. Cavallo D., Ursine C.L., Omodeo-sale E., Ianicoli S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. Mutat. Res. 2007, 628:11-18.
9. Chibber R., Ord M.J. The mutagenic and carcinogenic properties of three second-generation-anti-tumour platinum compounds: a comparison with cisplatin. Eur. J. Cancer Clin. Oncol. 1989, 25:27-53.
10. Cornetta T., Dadua L., Testa A., Ievoli E., Festa F., Trango G., et al. Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat. Res. 2008, 638:75-82.
11. De chaudhuri S., Kundu M., Banerjee M., Majundar P., Basu S., Roychoudhury S., Singh K., Giri K. Arsenic-induced health effects and genetic damage in keratotic individuals: involvement of p53 arginine variant and chromosomal aberrations in arsenic susceptibility. Mutat. Res. 2008, 659:118-125.
12. Di Giorgio C., De Méo M.P., Laget M., Guiraud H., Botta A., Duménil G. The micronucleus assay in human lymphocytes screening for inter-individual variability and application to biomonitoring. Carcinogenesis 1994, 15:7-313.
13. Ensslin A.S., Huber R., Pethran A., Rommelt H., Shierl R., Kulka U., Fruhmann G. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies. Int. Arch. Occup. Environ. Health 1997, 70:205-208.
14. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 445:81-95.
15. Fucic A., Jazbec A., Mijic A., Seso-Simic D., Tomek R. Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat. Res. 1998, 416:59-66.
16. Goloni-Bertolio E.M., Tajara E.H., Manzato A.J., Varella-Garcia M. Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int. J. Cancer 1992, 50:341-344.
17. Hagmar L., Bonassi S., Stronberg U., Brogger A., Knudsen L., Norppa H., Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer-a report from the European study group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 1998, 58:4117-4121.
18. Hansen J., Olsen J.H. Cancer morbidity among Danish female pharmacy technicians. Scand. J. Work Environ. Health 1994, 20:22-26.
19. Hessel H., Radon K., Pethran A., Maisch B., Grobmai S., Sauther I., Fruhmann G. The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs evaluation by the nucleus assay. Mutat. Res. 2001, 497:101-109.
20. IARC Some Antineoplastic and Immunosuppressive Agents 1981, vol. 26. IARC, Lyon, France.
21. Konnaris C., Valic E., Rudiger H.W. Long term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy drugs. Int. Arch. Occup. Environ. Health 2000, 73:442-448.
22. Kopjar N., Garaj-vrhovac V., Kasuba V., Rozgaz R., Ramic S., Pavlica V., Zeljezica D. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drug: a multi-biomarker approach. Int. J. Hyg. Environ. Health 2009, 212:414-431.
23. Lamberti L., Ponzetto P.B., Artido G. Cell kinetics and sister chromatid exchange frequency in human lymphocytes. Mutat. Res. 1983, 120:193-199.
24. Mc Diarmid M., Egan T. Acute occupational exposure to anti-neoplastic agents. J. Occup. Med. 1988, 30:984-987.
25. Machado-Santelli G.M., Cerqueira E.M., Oliveira C.T., De Braganca Pereira C.A. Biomonitoring of nurses handling antineoplastic drugs. Mutat. Res. 1994, 322:203-208.
26. Mader R.M., Kokalj A., Kratochvil E., Pilger A., Rudiger H.W. Longitudinal biomonitoring of nurses handling antineoplastic drugs. J. Clin. Nurs. 2008, 18:263-269.
27. Maki-Paakkanan J., Walles S., Osterman-Golker S., Norppa H. Single strand breaks, chromosome aberrations, sister-chromatid exchanges and micronuclei in blood lymphocytes of workers exposed to styrene during the production of reinforced plastics. Environ. Mol. Mutagen. 1991, 17:27-31.
28. Nikula E., Kivinity K., Leisti J., Taskinen P.J. Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scand. J. Work Environ. Health 1984, 10:71-74.
29. NIOSH Alert Document Preventing Occupational Exposure to Antineoplastic and other Hazardous Drugs in health care settings 2004, US Department of Health and Human Service, Public Occupational Safety and Health DHHS, NIOSH Publication No. 2004-165.
30. Norppa H. Genetic polymorphisms and chromosome damage. Int. J. Hyg. Environ. Health 2001, 204:31-38.
31. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 2004, 149:309-334.
32. OSHA Work Practice Guidelines for personnel dealing with cytotoxic (antineoplastic) drugs 1986, US, Dept. Labor, Washington, DC, Instruction Publication 8-1.1, Office of Occupational Medicine.
33. Pilger A., Kohler I., Stettnet H., Mader R.M., Rizovski B., Terkola R., Diem E., Franz-Haimg E., Konnaris C., Valic E., Rudiger H.W. Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs. Int. Arch. Occup. Environ. Health 2000, 73:442-448.
34. Rosin M.P. The use of the micronucleus test on exfoliated cells to identify anti-clastogenic action in humans: a biological marker for the efficacy of chemopreventive agents. Mutat. Res. 1992, 267:265-276.
35. Rossner P., Boffetta P., Ceppi M., Bonassi S., Smerhovsky Z., Landa K., Juzova D., Sram R. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ. Health Perspect. 2005, 113:517-520.
36. Sari-Minodier I., Orsière T., Bellon L., Pompili J., Sapin C., Botta A. Cytogenetic monitoring of industrial radiographers using the micronucleus assay. Mutat. Res. 2002, 521:37-46.
37. Sarto F., Trevisan A., Tomanim R., Canova A., Fiorentino M. Chromosomal aberrations, sister chromatid exchange, and urinary thioethers in nurses handling antineoplastic drugs. Am. J. Ind. Med. 1990, 18:689-695.
38. Selevan S.G., Lindbohm M.L., Horung R.W., Hemminki K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New Engl. J. Med. 1992, 313:1173-1178.
39. Sessink P.J.M., Van De Kerkhof M.C.A., Anzion R.B.M., Noordhoek J., Bos R.P. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?. Arch. Environ. Health 1994, 49:165-169.
40. Singh B., Gupta R.S. Mutagenic responses of thirteen anti-cancer drugs on mutation induction of multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells. Cancer Res. 1988, 43:577-584.
41. Skov T., Lynge E., Maarup B., Olsen J., Rorth M., Winthereik H. Risks for physicians handling antineoplastic drug [letter]. Lancet 1990, 336-446.
42. Skov T., Maarup B., Olsen J., Rorth M., Winthereik H., Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Brit. J. Ind. Med. 1992, 49:855-861.
43. Sorsa M., Hemminki K., Vaino H. Occupational exposure to anticancer drugs. Potential and real hazards. Mutat. Res. 1985, 154:49-135.
44. Sorsa M., Pyy L., Salomaa S., Nylund L.L., Yager J.W. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutat. Res. 1988, 204:465-479.
45. Stucker I., Hirsch A., Doloy T., Bastie-Sigeac I., Hemon D. Urine mutagenicity chromosomal abnormalities and sister-chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. Int. Arch. Occup. Environ. Health 1986, 57:195-205.
46. Thiringer G., Granung G., Holmen A., Hogstedt B., Jarvholm B., Jonsson D., Persson L., Wahlstrom J., Westin J. Comparison of methods for the biomonitoring of nurses handling antitumor drugs. Scand. J. Work Environ. Health 1991, 17:133-138.
47. Xue K.X., Wang S., Ma G.J., Zhou P., Wu P.G., Zhang R.F., Xu Z., Chen W.S., Wang Y.Q. Micronucleus formation in peripheral-blood lymphocytes smokers and the influence of alcohol and tea drinking habits. Int. J. Cancer 1992, 50:5-702.